India · Delayed Price · Currency is INR Anthem Biosciences Statistics
Total Valuation
NSE:ANTHEM has a market cap or net worth of INR 389.31 billion. The enterprise value is 380.09 billion.
| Market Cap | 389.31B |
| Enterprise Value | 380.09B |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:ANTHEM has 561.61 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 561.61M |
| Shares Outstanding | 561.61M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 80.41% |
| Owned by Institutions (%) | 7.08% |
| Float | 61.92M |
Valuation Ratios
The trailing PE ratio is 80.83 and the forward PE ratio is 58.70. NSE:ANTHEM's PEG ratio is 2.40.
| PE Ratio | 80.83 |
| Forward PE | 58.70 |
| PS Ratio | 19.44 |
| PB Ratio | 14.14 |
| P/TBV Ratio | 14.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.40 |
Enterprise Valuation
| EV / Earnings | 78.42 |
| EV / Sales | 18.98 |
| EV / EBITDA | 51.48 |
| EV / EBIT | 59.07 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | n/a |
| Interest Coverage | 123.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 23.51% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 10.20M |
| Profits Per Employee | 2.47M |
| Employee Count | 1,825 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ANTHEM has paid 2.40 billion in taxes.
| Income Tax | 2.40B |
| Effective Tax Rate | 33.12% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 644.83 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 66.56 |
| Average Volume (20 Days) | 279,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ANTHEM had revenue of INR 20.02 billion and earned 4.85 billion in profits. Earnings per share was 8.58.
| Revenue | 20.02B |
| Gross Profit | 11.91B |
| Operating Income | 6.43B |
| Pretax Income | 7.25B |
| Net Income | 4.85B |
| EBITDA | 7.37B |
| EBIT | 6.43B |
| Earnings Per Share (EPS) | 8.58 |
Balance Sheet
The company has 10.32 billion in cash and 1.10 billion in debt, with a net cash position of 9.22 billion or 16.41 per share.
| Cash & Cash Equivalents | 10.32B |
| Total Debt | 1.10B |
| Net Cash | 9.22B |
| Net Cash Per Share | 16.41 |
| Equity (Book Value) | 27.53B |
| Book Value Per Share | 49.04 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 59.49%, with operating and profit margins of 32.13% and 24.20%.
| Gross Margin | 59.49% |
| Operating Margin | 32.13% |
| Pretax Margin | 36.19% |
| Profit Margin | 24.20% |
| EBITDA Margin | 36.80% |
| EBIT Margin | 32.13% |
| FCF Margin | n/a |
Dividends & Yields
NSE:ANTHEM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
| Earnings Yield | 1.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |